HIM
HAE icon

Hillsdale Investment Management’s Haemonetics HAE Stock Holding History

Hillsdale Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-49,230
Closed -$4.21M – 632
2023
Q4 		$4.21M Sell
49,230
-110
-0.2% -$9.51K 0.34% 96
2023
Q3 		$4.42M Buy
49,340
+20
+0% +$1.79K 0.4% 72
2023
Q2 		$4.2M Sell
49,320
-18,280
-27% -$1.55M 0.39% 96
2023
Q1 		$5.59M Buy
67,600
+8,700
+15% +$704K 0.48% 62
2022
Q4 		$4.63M Buy
+58,900
New +$4.73M 0.39% 89
2020
Q3 		– Sell
-6,900
Closed -$618K – 608
2020
Q2 		$618K Sell
6,900
-30,860
-82% -$3.12M 0.06% 285
2020
Q1 		$3.76M Sell
37,760
-800
-2% -$86.7K 0.45% 48
2019
Q4 		$4.43M Buy
38,560
+4,200
+12% +$508K 0.39% 80
2019
Q3 		$4.33M Buy
34,360
+27,460
+398% +$3.49M 0.38% 60
2019
Q2 		$830K Buy
6,900
+1,300
+23% +$128K 0.08% 214
2019
Q1 		$490K Sell
5,600
-19,100
-77% -$1.74M 0.04% 321
2018
Q4 		$2.47M Buy
24,700
+7,700
+45% +$809K 0.29% 52
2018
Q3 		$1.95M Hold
17,000
– – 0.26% 62
2018
Q2 		$1.52M Sell
17,000
-1,000
-6% -$84.4K 0.19% 95
2018
Q1 		$1.32M Sell
18,000
-5,000
-22% -$343K 0.18% 102
2017
Q4 		$1.34M Buy
+23,000
New +$1.21M 0.22% 91

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hillsdale Investment Management's HAE Position: Q1 2024 in Review

Hillsdale Investment Management sold out of Haemonetics (HAE) in Q1 2024, closing a stake of 49,230 shares — an estimated $4.21M sold.

Hillsdale Investment Management first reported a position in HAE in Q4 2017 and held it in 16 quarters. The position peaked at $5.59M in Q1 2023. 298 funds tracked by Wall St. Rank hold HAE as of Q1 2024.

  • Hillsdale Investment Management reported no remaining Haemonetics position as of Q1 2024 after selling out during the quarter.
  • Hillsdale Investment Management sold 49,230 Haemonetics shares in Q1 2024, an estimated $4.21M.
  • Hillsdale Investment Management first reported a position in Haemonetics in Q4 2017 and held it in 16 quarters.
  • Hillsdale Investment Management's Haemonetics position peaked at $5.59M in Q1 2023.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q1 2024.

Based on Hillsdale Investment Management's 13F filing for Q1 2024, filed 10 May 2024.